Skip to main content

Advertisement

Table 2 Summary of Patients Characteristics

From: Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer

Variable All patients (n = 112)
Median age (years)a 69 (32–85)
Sex, n (%)
 M 84 (75.0%)
 F 28 (25.0%)
Histologic subtype, n (%)
 Adenocarcinoma 72 (64.3%)
 Squamous cell carcinoma 28 (25.0%)
 Other 12 (10.7%)
TNM stage
 T1/T2/T3/T4 25 / 47 / 10 / 30
 N0/N1/N2/N3 29 / 13 / 41 / 29
 M0/M1 63 / 49
 Stage I / II / III / IV 16 / 1 / 47 / 48
Treatment, n (%)
 Chemotherapy 82 (73.2%)
 Surgery 21 (18.8%)
 Radiation 1 (0.9%)
 Surgery + Chemotherapy 8 (7.1%)
  1. aNumbers in parentheses are ranges